Antimicrobial Resistance Surveillance Study in 2008 on the Nosocomial Enterobacteriaceae Strains Isolated from 15 Teaching Hospitals in China
WANG,Minjun CHEN,Hui Wang,Yunjian HU,Yuxing NI,Jingyong SUN,Yunsong YU,Haishen KONG,Lin HE,Weiyuan WU,Huifen YE,Yinmei YANG,Dachun HU,Haiyan QIN,Ping JI,Zhenhong ZHU,Jiankang REN,Lixia ZHANG,Xuhui ZHU,Mingqing TONG,Wangsheng ZHAO,Yaning MEI,Yong LIU,Zhijie ZHANG,Qiong DUAN,Dan LI,Pengpeng LIU,Jing WANG,Lixia HAN,Xiuli XIE
DOI: https://doi.org/10.3969/j.issn.1009-7708.2012.03.008
2012-01-01
Abstract:Objective To investigate the antimicrobial resistance in nosocomial Enterobacteriaceae isolates collected from 15 teaching hospitals located at different regions of China in 2008.Methods According to the study protocol,a total of 1 357 nonduplicate nosocomial strains of Enterobacteriaceae were collected and sent to the central lab for re-identification and susceptibility testing.The minimum inhibitory concentrations(MICs) of 15 antimicrobial agents were determined by agar dilution method.WHONET 5.6 software was used to analyze the data.Results The antimicrobial agents exhibiting high in vitro activity against Escherichia coli,Klebsiella pneumoniae and Proteus mirabilis included meropenem(to which 97.6%-100% of the strains were susceptible),panipenem(79.8%-98.4%),imipenem(64.9%-98.1%),ertapenem(91.3%-97.4%),piperacillin-tazobactam(87.2%-97.4%),cefmetazole(82.1%-97.0%) and amikacin(89.9%-93.8%).Meropenem(to which 98.7% of the strains were susceptible),panipenem(96.4%),imipenem(95.4%) and amikacin(85.7%) were highly active against Enterobacter spp.Carbapenems(92.0%-100%),piperacillin-tazobactam(93.1%-99.1%),amikacin(89.0%-94.3%) and cefepime(86.2%-93.1%) displayed high activity against Citrobacter freundii and Serratia marcescens.Conclusions Carbapenem,piperacillin-tazobactam and amikacin remain highly active against nosocomial strains of Enterobacteriaceae,while cefmetazole exhibited high activity against Escherichia coli,Klebsiella pneumoniae and Proteus mirabilis isolates.